Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sensus Healthcare Inc (SRTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,577
  • Shares Outstanding, K 16,405
  • Annual Sales, $ 26,430 K
  • Annual Income, $ -2,020 K
  • 60-Month Beta -0.44
  • Price/Sales 4.72
  • Price/Cash Flow N/A
  • Price/Book 4.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.03
  • Number of Estimates 4
  • High Estimate 0.00
  • Low Estimate -0.04
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.19 +2.23%
on 03/21/19
9.23 -20.37%
on 03/15/19
-0.40 (-5.16%)
since 02/22/19
3-Month
6.02 +22.09%
on 12/26/18
9.23 -20.37%
on 03/15/19
+1.19 (+19.32%)
since 12/21/18
52-Week
5.00 +47.00%
on 04/20/18
9.23 -20.37%
on 03/15/19
+1.53 (+26.29%)
since 03/22/18

Most Recent Stories

More News
Sensus Healthcare to Present at the 31st Annual ROTH Conference

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today the launch...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
U.S. FDA Grants Market Clearance to Sensus Healthcare's New Sculptura(TM) Radiation Oncology System

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radiation Therapy to Treat Non-Melanoma Skin Cancers and Keloids

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloid scars with Image-Guided Superficial Radiation...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100(TM) for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy...

SRTS : 7.35 (-3.42%)
SRTSU : 6.45 (-0.77%)
Report: Exploring Fundamental Drivers Behind Affimed N.V, Sensus Healthcare, Lifetime Brands, SigmaTron International, Salem Media Group, and Origin Agritech -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Affimed N.V. (NASDAQ:AFMD),...

AFMD : 4.00 (-4.31%)
LCUT : 9.45 (+0.43%)
SEED : 6.78 (-2.40%)
SRTS : 7.35 (-3.42%)
SALM : 2.59 (+2.37%)
SGMA : 2.88 (+3.23%)
SRTSU : 6.45 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade SRTS with:

Business Summary

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare,...

See More

Key Turning Points

2nd Resistance Point 7.74
1st Resistance Point 7.55
Last Price 7.35
1st Support Level 7.22
2nd Support Level 7.08

See More

52-Week High 9.23
Fibonacci 61.8% 7.61
Last Price 7.35
Fibonacci 50% 7.11
Fibonacci 38.2% 6.62
52-Week Low 5.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar